Technical Analysis for ORPH - Open Orphan Plc

Grade Last Price % Change Price Change
C 43.0 -2.16% -0.95
ORPH closed down 2.16 percent on Friday, April 16, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ORPH trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -2.16%
Boomer Buy Setup Bullish Swing Setup -2.16%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.16%
Calm After Storm Range Contraction -2.16%
NR7 Range Contraction -2.16%
Older End-of-Day Signals for ORPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago
1.5x Volume Pace 1 day ago
Fell Below Previous Day's Low 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Open Orphan Plc Description

Venn Life Sciences Holdings plc is a clinical research organization (CRO), which is engaged in providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations. The Company has the innovation segment, which is focused on developing and commercializing skin technologies. It provides drug development services through its subsidiary, Kinesis Pharma B.V. The Company's drug development services include clinical development, pharmaceutical development, non-clinical/pre-clinical development, drug candidate selection and drug development project management. The Company offers international clinical research services, including protocol development; feasibility and site selection; investigator and site selection; project management; site management and monitoring; vendor management, and quality assurance. The Company has its presence in the United Kingdom, Ireland, France, Netherlands, Germany and Singapore.


Classification

Keywords: Health Research Pharmaceutical Quality Biotechnology Science Organizations Clinic Monitoring Suit Life Sciences Consulting Skin Project Management Medical Device Clinical Trial Novation Pharmaceutical Industry Innovation Drug Discovery Search Service Drug Development Clinical Research Quality Assurance Contract Research Organizations Parexel Clinical Research Services Clinical Trial Services Drug Development Services Pharmaceutical Development Site Management

Is ORPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.0
52 Week Low 4.5
Average Volume 3,924,178
200-Day Moving Average 21.73
50-Day Moving Average 32.28
20-Day Moving Average 36.66
10-Day Moving Average 41.10
Average True Range 2.68
ADX 45.66
+DI 31.48
-DI 16.83
Chandelier Exit (Long, 3 ATRs ) 39.97
Chandelier Exit (Short, 3 ATRs ) 37.03
Upper Bollinger Band 47.40
Lower Bollinger Band 25.91
Percent B (%b) 0.8
BandWidth 58.63
MACD Line 3.78
MACD Signal Line 3.03
MACD Histogram 0.7449
Fundamentals Value
Market Cap 287.23 Million
Num Shares 668 Million
EPS
Price-to-Sales 8.93
Price-to-Book 6.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.99
Resistance 3 (R3) 51.24 48.84 49.66
Resistance 2 (R2) 48.84 46.81 48.71 49.21
Resistance 1 (R1) 45.92 45.55 44.72 45.66 48.77
Pivot Point 43.51 43.51 42.91 43.39 43.51
Support 1 (S1) 40.60 41.48 39.39 40.34 37.23
Support 2 (S2) 38.19 40.22 38.06 36.79
Support 3 (S3) 35.27 38.19 36.34
Support 4 (S4) 35.01